Browse studies, page 713
Page 713 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Stability indicating hplc method development and validation for the simultaneous estimation of metformin hydrochloride and dapagliflozin in API and pharmaceutical dosage form International Research Journal of Pharmacy, 2021
- Neurobehavioural, Biochemical and Histological Effects of Metformin in a Scopolamine-Induced Cognitive Impairment Model in Male Wistar Rats 2026
- Combination Therapy Including Metformin hydrochloride for the Treatment of Diabetes and Related Comorbidity: A Patent Filed Survey Organic and Medicinal Chemistry International Journal, 2017
- Valuation of environmental influence of recently invented high‐performance liquid chromatographic method for hypoglycemic mixtures of gliflozins and metformin in the presence of melamine impurities: Application of molecular modeling simulation approach Journal of Separation Science, 2023
- Facile hplc/UV method for determination of metformin and 1-cyanoguanidine using novel halogenated stationary phase Bulletin of Pharmaceutical Sciences Assiut, 2022
- In silico screening of some OLD drugs for NEW approaches in heart failure The Medical-Surgical Journal, 2023
- Stability indicating hplc method development and validation for simultaneous estimation of dapagliflozin and metformin tablet dosage form Asian Journal of Pharmaceutical and Clinical Research, 2022
- Pharmacokinetic Evaluation of Antidiabetic FDCs - An In-Silico Approach Medical and Pharmaceutical Journal, 2026
- Use of a sodium--glucose cotransporter 2 inhibitor, empagliflozin, in a patient with Rabson-Mendehall Syndrome 2021
- Investigating and Comparing the Lethal Effect of Nanoempagliflozin and Metformin on the U87 Cancer Cell Line in Human Glioblastoma Journal of Nanotechnology, 2025
- Analytical method development and validation of empagliflozin via RP-HPLC and UV spectrophotometric technique Journal of Integrative and Translational Biomedicine, 2026
- ANTIPROLIFERATIVE EFFECTS OF EMPAGLIFLOZIN ON HUMAN PANCREATIC CANCER MIA PaCa-2 CELLS Acta Medica Nicomedia, 2026
- Potensi kombinasi senyawa bioaktif kumis kucing DAN daun yakon sebagai terapi diabetes mellitus: studi in silico DAN prediksi admet Journal of Public Health Science, 2025
- Comparative ADMET Profiling and Pharmacokinetic Assessment of Metformin and Empagliflozin for Drug Repurposing Potential in CKD Zenodo (CERN European Organization for Nuclear Research), 2026
- Multi-omics and artificial intelligence for precision drug discovery and potential clinical applications Signal transduction and targeted therapy, 2026
- Guideline-Directed Medical Therapy for Diabetic Kidney Disease: Advances in Primary and Secondary Prevention Cureus, 2026
- Early Treatment with Empagliflozin and GABA Improves β-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice Journal of Diabetes Research, 2019
- A review on pharmacology and therapeutic effects of empagliflozin in patients with type 2 diabetes mellitus Asian Journal of Pharmaceutical and Clinical Research, 2020
- Metformin: From diabetes to cancer to prolongation of life Pharmacological Research, 2024
- Empagliflozin in Acute Myocardial Infarction Reduces No-Reflow and Preserves Cardiac Function by Preventing Endothelial Damage JACC Basic to Translational Science, 2024
- Metformin Attenuates Postinfarction Myocardial Fibrosis and Inflammation in Mice International Journal of Molecular Sciences, 2021
- Empagliflozin restores cardiac metabolic flexibility in diet-induced obese C57BL6/J mice Current Research in Physiology, 2022
- Liver Transcriptomic Reveals Novel Pathways of Empagliflozin Associated With Type 2 Diabetic Rats Frontiers in Endocrinology, 2020
- The Future of Metformin in the Prevention of Diabetes-Related Osteoporosis Cureus, 2020
- A Pharmaceutical Study on Quality Surveillance of Six Empagliflozin (10 mg) Tablet Generics in Pakistan Journal of Hunan University Natural Sciences, 2023
- Drug delivery system for controlled release of empagliflozin from alginate-chitosannanocarrier system TURKISH JOURNAL OF CHEMISTRY, 2022
- Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence Biomolecules, 2021
- Advantages of metformin for a diversity of diseases International Journal of Pharma Professional’s Research (IJPPR), 2023
- Empagliflozin as a new management strategy on outcomes in patients with type 2 diabetes mellitus Diabetes Mellitus, 2016
- Effect of Empagliflozin on Candida glabrata Adhesion to Vaginal Epithelial Cells Medical Mycology Journal, 2022
- Metformin: A Dual-Role Player in Cancer Treatment and Prevention International Journal of Molecular Sciences, 2024
- Cardiovascular Effects of Metformin Rational Pharmacotherapy in Cardiology, 2022
- Exorbitant Drug Loading of Metformin and Sitagliptin in Mucoadhesive Buccal Tablet: In Vitro and In Vivo Characterization in Healthy Volunteers Pharmaceuticals, 2022
- Empagliflozin: a new strategy for nephroprotection in diabetes Diabetes Mellitus, 2017
- Formulation and Evaluation of Bilayer Fixed Dose Combination Tablets Containing Empagliflozin, Sitagliptin and Metformin as Triple Therapy in Diabetes International Journal of Pharmaceutical Sciences Review and Research, 2025
- P0967ENHANCING podocyte regeneration with bromoindirubin-3´-oxime (BIO) as a potential terapeutic target in diabetic kidney disease 2020
- 1011-P: Therapeutic Potential of Novel Combination of a Long-Acting Glucagon Analog (HM15136) and Antidiabetic Drugs for the Treatment of Obesity Diabetes, 2019
- P1008THERAPY with sodium-glucose cotransporter type 2 inhibitors increases klotho in type 2 diabetic patients 2020
- Synthesis of TMPA Derivatives through Sequential Ir(III)-Catalyzed C–H Alkylation and Their Antidiabetic Evaluation ACS Omega, 2018
- MO640: Treatment with Sodium–Glucose Cotransporter 2 Inhibitors Increases Klotho in Type 2 Diabetic Patients Nephrology, Dialysis and Transplantation, 2022
- Fabrication of a Redox-Reversible Near-Infrared Fluorogenic Probe for Ferroptosis Process Monitoring and the Early Diagnosis of Diabetes Analytical Chemistry, 2025
- Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics Pharmacogenetics & Genomics, 2013
- 18. association of tumor pathological complete response with the USE of metformin during neoadjuvant chemoradiotherapy in esophageal cancer patients: retrospective study Diseases of the esophagus, 2023
- Sustainable HPLC technique for measurement of antidiabetic drugs: Appraisal of green and white metrics, content uniformity, and in vitro dissolution Analitical chemistry (Tel Aviv, 1993), 2024
- HD-6277, a Novel GPR40 Agonist, Improves Glucose Homeostasis and Enhanced Glucose-Dependent Insulin Secretion in Beta Cells and Type 2 Diabetic Rats Diabetes, 2018
- Design and Optimization of Pulsatile and Extended-Release Bilayer Tablets for Chronomodulated Delivery of Antidiabetic Drugs Using Box-Behnken Model International Journal of Current Pharmaceutical Research, 2026
- Treatment of Hyperglycemia with Empagliflozin, With or Without Metformin, Improves Islet Endothelial Cell Health and Insulin Secretion in db/db Diabetic Mice Diabetes, 2018
- Pathogenesis and Therapeutic Perspectives of Tubular Injury in Diabetic Kidney Disease: An Update Biomedicines, 2025
- Addressing Meta-Inflammation in the Comprehensive Management of Chronic Pain Cureus, 2025
- Dual GIP/GLP1-RA, GCGR/GLP-1 RA and GLP1-RA for the Treatment of Metabolic Dysfunction-associated Steatotic Liver Disease with Type 2 Diabetes: A Systematic Review and Meta-analysis TouchREVIEWS in endocrinology, 2025
- Bridging Innovation and Practice in Type 2 Diabetes Mellitus: Novel Antidiabetic Therapies and the Expanding Role of Community Pharmacists Pharmaceuticals (Basel, Switzerland), 2026
- Personalised Approach to the Management of Older People with Type 2 Diabetes Mellitus-A Comprehensive Narrative Review Journal of personalized medicine, 2026
- Frailty-stratified effectiveness of SGLT2 inhibitors versus DPP-4 inhibitors and GLP-1 receptor agonists on pulmonary outcomes in type 2 diabetes: a nationwide cohort study EClinicalMedicine, 2025
- Methicillin-Sensitive Staphylococcus aureus-Associated Leukocytoclastic Vasculitis: A Case Report and Literature Review Cureus, 2024
- Comparative efficacy and safety of antidiabetic agents for post-transplant diabetes mellitus: a network meta-analysis Frontiers in medicine, 2025
- Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
- Comparing the Efficacy and Long-Term Outcomes of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Metformin, and Insulin in the Management of Type 2 Diabetes Mellitus Cureus, 2024
- Risk of fracture with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: an updated meta-analysis of randomized controlled trials International journal of physiology, pathophysiology and pharmacology, 2025
- Association between sodium-glucose co-transporter-2 inhibitors and cardiac outcomes in cancer patients: a systematic review and meta-analysis Journal of geriatric cardiology : JGC, 2025
- Efficacy and Safety of Antidiabetic Agents for Major Depressive Disorder and Bipolar Depression: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials Journal of clinical medicine, 2024
- Cardio-Renal Metabolic Syndrome: An Integrated Approach to Prevention and Management Cureus, 2025
- Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study The Lancet regional health. Europe, 2026
- Semaglutide alleviates osteoarthritis independent of weight loss via GLP-1R-mediated activation of autophagy through AKT/mTOR inhibition Journal of orthopaedic translation, 2026
- Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Mellitus: An Umbrella Review of Systematic Reviews Diabetes, metabolic syndrome and obesity : targets and therapy, 2025
- Glucagon-like peptide-1 receptor agonists in total joint arthroplasty: a comprehensive systematic review of what orthopaedic surgeons should know Arthroplasty (London, England), 2026
- Animal studies of sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease Annals of gastroenterology, 2024
- A Scoping Review of the Effect of Intermittent Fasting on Diabetes Regulation and Weight Control Indian journal of endocrinology and metabolism, 2025
- The Effect of Semaglutide on Pancreatic β-Cell Function in Adults with Type 2 Diabetes: A Systematic Review and Meta-Analysis Journal of clinical medicine, 2025
- Gut Microbiota-Directed Interventions in Type 2 Diabetes: A Systematic Review of Clinical Outcomes and Complication Risk Cureus, 2025
- Empagliflozin reduces brain pathology in Alzheimer’s disease and type 2 diabetes Neural Regeneration Research, 2023
- Effects of metformin on knee joint capsule fibrosis in a diabetic mouse model Bone and Joint Research, 2024
- Empagliflozin Ameliorates Preeclampsia and Reduces Postpartum Susceptibility to Adriamycin in a Mouse Model Induced by Angiotensin Receptor Agonistic Autoantibodies Frontiers in Pharmacology, 2022
- Metformin: new insights into an archetypal cardiometabolic drug Cardiovascular Endocrinology, 2017
- Elucidating Carfilzomib’s Induced Cardiotoxicity in an In Vivo Model of Aging: Prophylactic Potential of Metformin International Journal of Molecular Sciences, 2021
- The dual role of empagliflozin: Cardio renal protection in T2DM patients Annals of Medicine and Surgery, 2022
- A Review of Animal Models for Studying Bone Health in Type-2 Diabetes Mellitus (T2DM) and Obesity International Journal of Molecular Sciences, 2024
- Animal Models for the Evaluation of the Cardiometabolic Therapeutic Potential of Traditional Chinese and Natural Product Medicines International Journal of Diabetology & Vascular Disease Research, 2017
- Empagliflozin in Type 2 Diabetes Mellitus Patients with High Cardiovascular Risk: A Model-Based Cost-Utility Analysis in China Diabetes Metabolic Syndrome and Obesity, 2020
- Effect of high-fat diet and empagliflozin on cardiac proteins in mice Nutrition & Metabolism, 2022
- Insights in animal models for translational cardiovascular research：A pharmaceutical industry perspective 2021
- Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice Diabetes Metabolic Syndrome and Obesity, 2023
- Genomic, Proteomic, and Metabolic Comparisons of Small Animal Models of Heart Failure With Preserved Ejection Fraction: A Tale of Mice, Rats, and Cats Journal of the American Heart Association, 2022
- The impact of combined decaffeinated green coffee and green tea, metformin, and empagliflozin on SAMD11 mRNA expression in vascular calcification associated with metabolic syndrome in Sprague Dawley rats Heart Science Journal, 2026
- Growth Differentiation Factor-15 and the Effect of Empagliflozin in Heart Failure: Findings from the EMPEROR Program European Journal of Heart Failure, 2023
- Translation Animal Models of Diabetic Kidney Disease: Biochemical and Histological Phenotypes, Advantages and Limitations Diabetes Metabolic Syndrome and Obesity, 2023
- Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASH Biomedicines, 2021
- Metabolic Effects of Metformin in the Failing Heart International Journal of Molecular Sciences, 2018
- The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review Diabetes Therapy, 2014
- FP410AN optimized animal model of progressive CKD in type 2 diabetes to improve predictability of preclinical drug testing Nephrology Dialysis Transplantation, 2018
- Empagliflozin: a wonder drug for the treatment of SIAD? Frontiers in Endocrinology, 2024
- Economic Spectrofluorometric Bioanalysis of Empagliflozin in Rats’ Plasma Journal of Analytical Methods in Chemistry, 2021
- Use of Animal Models for Investigating Cardioprotective Roles of SGLT2 Inhibitors Journal of Cardiovascular Translational Research, 2023
- Preventive effect of empagliflozin and ezetimibe on hepatic steatosis in adults and murine models Biomedicine & Pharmacotherapy, 2023
- FO051Glycogen synthase kinases 3-α/β inhibition attenuates progression of diabetic kidney disease beyond treatment with metformin/Ramipril/empagliflozin Nephrology Dialysis Transplantation, 2019
- Enhanced anticancer effect of lysozyme-functionalized metformin-loaded shellac nanoparticles on a 3D cell model: role of the nanoparticle and payload concentrations Biomaterials Science, 2024
- Simultaneous Estimation of Empagliflozin and Metformin by High-Performance Thin-Layer Chromatography Using Quality-by-Design Approach Jpc-journal of Planar Chromatography-modern Tlc, 2019
- The role of the cholinergic system in the memory-protecting effects of metformin in a model of scopolamine-induced memory impairment in aged rats Behavioural Brain Research, 2024
- Initiation of Metformin in Early Pregnancy Results in Fetal Bioaccumulation, Growth Restriction & Renal Dysmorphology in a Primate Model American Journal of Obstetrics and Gynecology, 2024
- The Impact of Metformin on Dust-Induced Histopathological Changes and Oxidative Stress in the Liver: An Insight into Dust Concentration and Liver Biomarkers in Animal Models Reports of Biochemistry and Molecular Biology, 2023
- Evaluating Spironolactone Monotherapy Against Combined Treatment with Metformin in Rat PCOS Model European Journal of Pharmacology, 2025
